Structural and functional analysis of the avian leukemia virus constitutive transport element.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 1369885)

Published in RNA on December 01, 1999

Authors

J Yang1, B R Cullen

Author Affiliations

1: Howard Hughes Medical Institute and Department of Genetics, Duke University Medical Center, Durham, North Carolina 27710, USA.

Articles citing this

The retrovirus RNA trafficking granule: from birth to maturity. Retrovirology (2006) 1.63

Both ran and importins have the ability to function as nuclear mRNA export factors. RNA (2002) 1.27

Rous sarcoma virus DR posttranscriptional elements use a novel RNA export pathway. J Virol (2000) 1.25

Directionality of nucleocytoplasmic transport of the retroviral gag protein depends on sequential binding of karyopherins and viral RNA. Proc Natl Acad Sci U S A (2010) 1.11

Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs. J Virol (2002) 1.03

Primary sequence and secondary structure motifs in spleen necrosis virus RU5 confer translational utilization of unspliced human immunodeficiency virus type 1 reporter RNA. J Virol (2003) 1.01

Tap and Dbp5, but not Gag, are involved in DR-mediated nuclear export of unspliced Rous sarcoma virus RNA. Virology (2007) 1.01

Mapping of the functional boundaries and secondary structure of the mouse mammary tumor virus Rem-responsive element. J Biol Chem (2009) 0.95

The R region found in the human foamy virus long terminal repeat is critical for both Gag and Pol protein expression. J Virol (2001) 0.93

An element in the 3' untranslated region of human LINE-1 retrotransposon mRNA binds NXF1(TAP) and can function as a nuclear export element. RNA (2002) 0.93

Identification and mutational analysis of a Rej response element in Jaagsiekte sheep retrovirus RNA. J Virol (2009) 0.92

Murine leukemia virus uses NXF1 for nuclear export of spliced and unspliced viral transcripts. J Virol (2014) 0.89

Cytoplasmic utilization of human immunodeficiency virus type 1 genomic RNA is not dependent on a nuclear interaction with gag. J Virol (2012) 0.86

Selective inhibition of splicing at the avian sarcoma virus src 3' splice site by direct-repeat posttranscriptional cis elements. J Virol (2000) 0.84

The HIV-1 Rev response element (RRE) adopts alternative conformations that promote different rates of virus replication. Nucleic Acids Res (2015) 0.83

Posttranscriptional regulation of retroviral gene expression: primary RNA transcripts play three roles as pre-mRNA, mRNA, and genomic RNA. Wiley Interdiscip Rev RNA (2013) 0.82

RNA processing control in avian retroviruses. Front Biosci (2008) 0.80

HIV-1 and M-PMV RNA Nuclear Export Elements Program Viral Genomes for Distinct Cytoplasmic Trafficking Behaviors. PLoS Pathog (2016) 0.80

Gammaretroviral pol sequences act in cis to direct polysome loading and NXF1/NXT-dependent protein production by gag-encoded RNA. Retrovirology (2014) 0.79

Molecular events accompanying rous sarcoma virus rescue from rodent cells and the role of viral gene complementation. J Virol (2014) 0.77

Evolutionary conservation of a molecular machinery for export and expression of mRNAs with retained introns. RNA (2015) 0.77

Diverse activities of viral cis-acting RNA regulatory elements revealed using multi-color, long-term, single cell imaging. Mol Biol Cell (2016) 0.75

Articles cited by this

CRM1 is an export receptor for leucine-rich nuclear export signals. Cell (1997) 18.60

Nucleotide sequence of Rous sarcoma virus. Cell (1983) 17.80

Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol (1987) 12.66

Exportin 1 (Crm1p) is an essential nuclear export factor. Cell (1997) 10.32

TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol Cell (1998) 5.85

The HIV-1 Rev protein. Annu Rev Microbiol (1998) 4.78

The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88. EMBO J (1997) 4.65

Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc Natl Acad Sci U S A (1990) 4.63

The Mex67p-mediated nuclear mRNA export pathway is conserved from yeast to human. EMBO J (1999) 4.49

A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci U S A (1994) 4.43

The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr Biol (1997) 4.35

Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J Virol (1991) 3.94

The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences. Genes Dev (1999) 3.24

The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J (1997) 3.10

The simian retrovirus-1 constitutive transport element, unlike the HIV-1 RRE, uses factors required for cellular mRNA export. Curr Biol (1997) 2.90

TAP binds to the constitutive transport element (CTE) through a novel RNA-binding motif that is sufficient to promote CTE-dependent RNA export from the nucleus. EMBO J (1999) 2.83

Nucleotide sequence of noncoding regions in Rous-associated virus-2: comparisons delineate conserved regions important in replication and oncogenesis. J Virol (1984) 2.71

Nucleoporins nup98 and nup214 participate in nuclear export of human immunodeficiency virus type 1 Rev. J Virol (1999) 2.37

Minimal Rev-response element for type 1 human immunodeficiency virus. J Virol (1991) 2.22

Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1. J Virol (1998) 2.18

Nuclear RNA export. Genes Dev (1998) 2.04

Endogenous avian retroviruses contain deficient promoter and leader sequences. Proc Natl Acad Sci U S A (1983) 1.90

Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J Virol (1996) 1.85

Retroviruses as model systems for the study of nuclear RNA export pathways. Virology (1998) 1.72

Identification of the activation domain of equine infectious anemia virus rev. J Virol (1993) 1.57

A single stem-loop structure within the HTLV-1 Rex response element is sufficient to mediate Rex activity in vivo. Virology (1994) 1.17

Rous sarcoma virus direct repeat cis elements exert effects at several points in the virus life cycle. J Virol (1997) 1.12

Mutational analysis of the rous sarcoma virus DR posttranscriptional control element. J Virol (1998) 1.06

Analysis of the RNA binding specificity of the human tap protein, a constitutive transport element-specific nuclear RNA export factor. Virology (1999) 1.04

Point mutations in the avian sarcoma/leukosis virus 3' untranslated region result in a packaging defect. J Virol (1999) 1.01

Structural and functional analysis of the visna virus Rev-response element. J Virol (1992) 0.97

Articles by these authors

(truncated to the top 100)

The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (1989) 13.92

Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol (1987) 12.66

Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell (1986) 10.71

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science (1991) 10.53

Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function. Cell (1989) 7.46

Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature (1988) 6.28

Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene (1988) 6.13

HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell (1990) 5.82

Transcriptional interference in avian retroviruses--implications for the promoter insertion model of leukaemogenesis. Nature (1984) 5.26

Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. Proc Natl Acad Sci U S A (1987) 4.91

HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell (1991) 4.61

Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J Exp Med (1991) 4.56

Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science (1986) 4.30

Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay. Mol Cell Biol (1996) 4.10

Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J Virol (1991) 3.94

Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat. J Virol (1988) 3.69

Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell (1995) 3.55

Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc Natl Acad Sci U S A (1989) 3.43

Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein. Nature (1988) 3.31

Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J Exp Med (1993) 3.29

The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences. Genes Dev (1999) 3.24

Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. Genes Dev (1989) 3.09

Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J (1998) 3.05

A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors. Nature (1987) 3.00

The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol Cell Biol (1999) 2.90

Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J Virol (1989) 2.89

HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor. EMBO J (1997) 2.86

Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol Cell Biol (1993) 2.79

Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J Virol (2000) 2.72

Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products. J Virol (1991) 2.62

Nuclear import of hnRNP A1 is mediated by a novel cellular cofactor related to karyopherin-beta. J Cell Sci (1997) 2.60

Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr Biol (1999) 2.52

The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes Dev (1992) 2.24

Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev action. Genes Dev (1990) 2.24

Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1. J Virol (1998) 2.18

Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J Virol (1993) 2.16

Characterization of the transcriptional trans activator of human foamy retrovirus. J Virol (1991) 2.12

Functional analysis of the transcription control region located within the avian retroviral long terminal repeat. Mol Cell Biol (1985) 2.12

Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc Natl Acad Sci U S A (1992) 1.96

Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J Exp Med (1992) 1.93

Efficient polyadenylation within the human immunodeficiency virus type 1 long terminal repeat requires flanking U3-specific sequences. J Virol (1991) 1.91

Endogenous avian retroviruses contain deficient promoter and leader sequences. Proc Natl Acad Sci U S A (1983) 1.90

A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. Nucleic Acids Res (1990) 1.90

Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species. Proc Natl Acad Sci U S A (1989) 1.87

Amphibian transcription factor IIIA proteins contain a sequence element functionally equivalent to the nuclear export signal of human immunodeficiency virus type 1 Rev. Proc Natl Acad Sci U S A (1996) 1.87

Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. Virology (1995) 1.84

Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc Natl Acad Sci U S A (1999) 1.82

Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science (1992) 1.76

Molecular basis of latency in pathogenic human viruses. Science (1991) 1.74

Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc Natl Acad Sci U S A (2000) 1.67

Transcriptional activity of avian retroviral long terminal repeats directly correlates with enhancer activity. J Virol (1985) 1.67

The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop. Proc Natl Acad Sci U S A (1998) 1.65

Genetic evidence that the Tat proteins of human immunodeficiency virus types 1 and 2 can multimerize in the eukaryotic cell nucleus. J Virol (1993) 1.62

Phosphorylation of the rev gene product of human immunodeficiency virus type 1. J Virol (1988) 1.61

Identification of a U5-specific sequence required for efficient polyadenylation within the human immunodeficiency virus long terminal repeat. J Virol (1989) 1.61

An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein. Proc Natl Acad Sci U S A (1999) 1.59

Mutational analysis of the transcription activation domain of RelA: identification of a highly synergistic minimal acidic activation module. Mol Cell Biol (1994) 1.58

Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates. J Virol (2001) 1.58

Identification of the activation domain of equine infectious anemia virus rev. J Virol (1993) 1.57

Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Proc Natl Acad Sci U S A (1990) 1.55

A nuclear role for the Fragile X mental retardation protein. EMBO J (1996) 1.54

COOH-terminal requirements for the correct processing of a phosphatidylinositol-glycan anchored membrane protein. J Biol Chem (1988) 1.52

Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway. Proc Natl Acad Sci U S A (1996) 1.52

APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep (2000) 1.50

Role of the avian retrovirus mRNA leader in expression: evidence for novel translational control. Mol Cell Biol (1986) 1.47

Effect of intron size on splicing efficiency in retroviral transcripts. Nucleic Acids Res (1982) 1.46

Expression of active, membrane-bound human placental alkaline phosphatase by transfected simian cells. Proc Natl Acad Sci U S A (1987) 1.44

Two closely related human nuclear export factors utilize entirely distinct export pathways. Mol Cell (2001) 1.43

The complete nucleotide sequence of the Vibrio harveyi bacteriophage VHML. J Appl Microbiol (2002) 1.43

In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax. Mol Cell Biol (1994) 1.43

The Bel-1 protein of human foamy virus activates human immunodeficiency virus type 1 gene expression via a novel DNA target site. J Virol (1992) 1.42

Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins. J Virol (1991) 1.41

Functional analysis of the Tat trans activator of human immunodeficiency virus type 2. J Virol (1989) 1.40

Determination of the functional domain organization of the importin alpha nuclear import factor. J Cell Biol (1998) 1.40

Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates. J Virol (1998) 1.36

Identification and functional characterization of a novel nuclear localization signal present in the yeast Nab2 poly(A)+ RNA binding protein. Mol Cell Biol (1998) 1.35

The human tap nuclear RNA export factor contains a novel transportin-dependent nuclear localization signal that lacks nuclear export signal function. J Biol Chem (1999) 1.28

Functional organization of the Bel-1 trans activator of human foamy virus. J Virol (1993) 1.27

Regulation of the human c-myc gene: 5' noncoding sequences do not affect translation. Mol Cell Biol (1985) 1.26

Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells. J Virol (1993) 1.24

Definition of a consensus transportin-specific nucleocytoplasmic transport signal. J Biol Chem (1999) 1.22

The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein. J Virol (1996) 1.22

Effect of RNA secondary structure on polyadenylation site selection. Genes Dev (1991) 1.21

Using viral species specificity to define a critical protein/RNA interaction surface. Genes Dev (2001) 1.20

Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region. J Virol (1989) 1.19

Derivation of a biologically contained replication system for human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 1.18

Sequence requirements for Rev multimerization in vivo. Virology (1994) 1.18

Chemokine receptors and human immunodeficiency virus infection. Front Biosci (1998) 1.18

Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef use distinct but overlapping target sites for downregulation of cell surface CD4. J Virol (1997) 1.17

A single stem-loop structure within the HTLV-1 Rex response element is sufficient to mediate Rex activity in vivo. Virology (1994) 1.17

The simian immunodeficiency virus Nef protein promotes degradation of CD4 in human T cells. J Biol Chem (1994) 1.17

Identification of regions in HIV-1 Nef required for efficient downregulation of cell surface CD4. Virology (1997) 1.14

Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases. RNA (1998) 1.13

The role of avian retroviral LTRs in the regulation of gene expression and viral replication. Adv Virus Res (1985) 1.13

Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain? Virology (1990) 1.12

Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism. Mol Cell Biol (1999) 1.07

Functional differences between human and bovine immunodeficiency virus Tat transcription factors. J Virol (2000) 1.07

Analysis of cellular factors that mediate nuclear export of RNAs bearing the Mason-Pfizer monkey virus constitutive transport element. J Virol (2000) 1.07

Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes. J Virol (1999) 1.06

The human endogenous retrovirus K Rev response element coincides with a predicted RNA folding region. RNA (2000) 1.04